drugset / Trial / NCT03743376
The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 Patients
Phase 2
Completed
31 enrolled
United BioPharma
Kaohsiung Medical University Chung-Ho Memorial Hospital · collabKaohsiung Veterans General Hospital. · collabNational Taiwan University Hospital · collabTaipei Veterans General Hospital, Taiwan · collabTaoyuan General Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This study evaluate the safety of UB-421 in combination with standard antiretroviral therapy (ART) and the efficacy of HIV reservoir reduction as compared with ART alone in ART stabilized HIV-1 patients
Timeline
- Start
- 2018-12-12
- Primary completion
- 2020-10-15
- Completion
- 2021-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SEMZUVOLIMAB | Protein / enzyme biologic | 25 mg/kg | Intravenous |